ÂÜÀòÂÒÂ×

David Szeto, PharmD, is a seasoned professional in the biotech and pharmaceutical industries, currently serving as a Senior Analyst at Great Point Partners since 2021. Prior experience includes roles in Biotech Equity Research at RBC Capital Markets from 2020 to 2021, Business Development & Licensing at Bayer from 2018 to 2020, and Market Access & Commercialization at 1798 from 2015 to 2018. David Szeto holds a PharmD from the University of California, San Francisco, a Master’s degree in NanoEngineering from UC San Diego, and a Bachelor’s degree in Mechanical Engineering with a focus on Materials Science Engineering from UC Irvine.